The News Is Not All Bad, or Good, for Infection Control

By McCann, Jean | Drug Topics, October 16, 2000 | Go to article overview

The News Is Not All Bad, or Good, for Infection Control


McCann, Jean, Drug Topics


As usual, this year's Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), which drew some 16,000 infectious disease specialists, pharmacists, and others to Toronto last month, generated both positive and negative reports.

The bad news: Antimicrobial resistance is still a major, increasing problem. For example, the SENTRY Antimicrobial Surveillance Program reported that antimicrobial resistance in community-acquired respiratory tract infections has reached "serious levels" over the past three years. In the United States, the rate of nonsusceptibility to macrolides (erythromycin, azithromycin, and clarithromycin) now equals the rate of penicillin resistance.

But the good news was also striking. For one thing, there's a new global brain trust, called the Alliance for the Prudent Use of Antibiotics (APUA). Sponsored by Bristol-Myers Squibb, SmithKline Beecham, and a global disease service company called MRL, APUA will collaborate with public health authorities to develop a comprehensive information source called GAARD (Global Advisory on Antibiotic Resistance Data). It will also encourage research in this area. (For further information or to learn how to join the advisory group's efforts, e-mail barbara.souder@ tufts.edu.)

In other good news, pharmaceutical companies reported promising clinical results with new agents and classes of agents as well as better ways to use existing drugs. These included better combinations; better dosing; and, in some cases, short courses rather than prolonged treatment.

Also under considerable discussion was the development of vactines to forestall the development of infections. According to Spotswood Spruance, M.D., of the University of Utah, one such vaccine (see page 29) looked promising in protecting about 74% of initially HSV negative women against genital herpes upon exposure. Also, a vaccine targeting Staphylococcus aureus, which is commonly picked up in health-care settings, reduced by more than half the cases of septicemia in a group of 1,800 kidney dialysis patients.

In children aged one to 12, the use of the oral flu drug oseltamivir (Tamiflu, Roche) during influenza was shown, in a multicenter study, to reduce subsequent otitis media by 56% in children aged one to five and by 40% in the overrall group, compared with children receiving a placebo.

First of a new class

The first of an entirely new family of antibiotics-the ketolides-looks promising, according to the results of 10 phase III multinational trials reported at the conference, and an NDA has been filed with the Food & Drug Administration for the approval of telithromycin tablets (Ketek, Aventis). The 2,500 patients treated with the new drug, which is a novel addition to the macrolide-- lincosamide-streptogramin group of agents, showed favorable responses to several of the common and less common causes of upper respiratory group infections. Subanalyses of the North American study, for instance, showed a 90% cure rate against the most common cause of community-acquired pneumonia, Streptococcus pneumoniae. It also showed activity against S. pyogenes, Staphylococcus aureus, Haemophilus influenzae, and Moraxella catarrhalis.

A fourth-generation cephalosporin, cefepime (Maxipime, Dura Pharmaceuticals), was shown to overcome the resistance seen in thirdgeneration drugs caused by extended=spectrum beta-lactamases and AmpC cephalosporinases in a small study of trauma patients at the University of Maryland. Of the 17 seriously ill patients, there was a clinical cure in 13 and a bacteriological cure in 15 against such organisms as Klebsiella pneumoniae, Escherichia coli, Enterobacter cloacae, and Citrobacter freundii.

Phase III data were also presented for another addition-in this country-to the cephalosporin class. Currently on the market in Japan, cefditoren pivoxil (Spectracef, TAP Pharmaceuticals) is being reviewed by the FDA for acute exacerbations of chronic bronchitis. …

The rest of this article is only available to active members of Questia

Already a member? Log in now.

Notes for this article

Add a new note
If you are trying to select text to create highlights or citations, remember that you must now click or tap on the first word, and then click or tap on the last word.
One moment ...
Default project is now your active project.
Project items

Items saved from this article

This article has been saved
Highlights (0)
Some of your highlights are legacy items.

Highlights saved before July 30, 2012 will not be displayed on their respective source pages.

You can easily re-create the highlights by opening the book page or article, selecting the text, and clicking “Highlight.”

Citations (0)
Some of your citations are legacy items.

Any citation created before July 30, 2012 will labeled as a “Cited page.” New citations will be saved as cited passages, pages or articles.

We also added the ability to view new citations from your projects or the book or article where you created them.

Notes (0)
Bookmarks (0)

You have no saved items from this article

Project items include:
  • Saved book/article
  • Highlights
  • Quotes/citations
  • Notes
  • Bookmarks
Notes
Cite this article

Cited article

Style
Citations are available only to our active members.
Buy instant access to cite pages or passages in MLA, APA and Chicago citation styles.

(Einhorn, 1992, p. 25)

(Einhorn 25)

1. Lois J. Einhorn, Abraham Lincoln, the Orator: Penetrating the Lincoln Legend (Westport, CT: Greenwood Press, 1992), 25, http://www.questia.com/read/27419298.

Cited article

The News Is Not All Bad, or Good, for Infection Control
Settings

Settings

Typeface
Text size Smaller Larger Reset View mode
Search within

Search within this article

Look up

Look up a word

  • Dictionary
  • Thesaurus
Please submit a word or phrase above.
Print this page

Print this page

Why can't I print more than one page at a time?

Help
Full screen

matching results for page

    Questia reader help

    How to highlight and cite specific passages

    1. Click or tap the first word you want to select.
    2. Click or tap the last word you want to select, and you’ll see everything in between get selected.
    3. You’ll then get a menu of options like creating a highlight or a citation from that passage of text.

    OK, got it!

    Cited passage

    Style
    Citations are available only to our active members.
    Buy instant access to cite pages or passages in MLA, APA and Chicago citation styles.

    "Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences." (Einhorn, 1992, p. 25).

    "Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences." (Einhorn 25)

    "Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences."1

    1. Lois J. Einhorn, Abraham Lincoln, the Orator: Penetrating the Lincoln Legend (Westport, CT: Greenwood Press, 1992), 25, http://www.questia.com/read/27419298.

    Cited passage

    Thanks for trying Questia!

    Please continue trying out our research tools, but please note, full functionality is available only to our active members.

    Your work will be lost once you leave this Web page.

    Buy instant access to save your work.

    Already a member? Log in now.

    Oops!

    An unknown error has occurred. Please click the button below to reload the page. If the problem persists, please try again in a little while.